Efficacy and Safety of Rituximab in the Treatment of Idiopathic Membranous Nephropathy: A Meta-Analysis
Background. Primary membranous nephropathy (MN), sometimes referred to as idiopathic membranous nephropathy (IMN), is a kind of MN whose pathogenesis is yet unclear. According to research reports, the incidence of IMN is about 9.8–26.8%, and it is on the rise. Methods. The computer retrieves eight d...
Saved in:
Main Authors: | Huijuan Lu, Jun Shen, Jieqiong Sun, Jia Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Applied Bionics and Biomechanics |
Online Access: | http://dx.doi.org/10.1155/2022/5393797 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploration of rituximab treatment strategies for membranous nephropathy adapted to the Chinese healthcare environment
by: Xiaolong Wang, et al.
Published: (2025-01-01) -
Transplant Outcomes in Patients with Idiopathic Membranous Nephropathy
by: Claire Kennedy, et al.
Published: (2013-01-01) -
The Potential Role of Regulatory B Cells in Idiopathic Membranous Nephropathy
by: Zhaocheng Dong, et al.
Published: (2020-01-01) -
Clinical study, network pharmacology, and molecular docking of Kunxian capsule in treating idiopathic membranous nephropathy
by: Jia Lv, et al.
Published: (2025-02-01) -
Efficacy and safety of Mahuang Fuzi and Shenzhuo Decoction for treatment of primary membranous nephropathy: a multicenter prospective trial
by: Naiqian Zhang, et al.
Published: (2024-12-01)